REG - Johnson Matthey PLC - Completion of Diagnostic Services sale

Johnson MattheyAnnouncement

02/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231002:nRSB2615Oa&default-theme=true

RNS Number : 2615O  Johnson Matthey PLC  02 October 2023

2(nd) October 2023

 

Johnson Matthey Plc

(the Company)

Johnson Matthey announces completion of Diagnostic Services (also known as
Tracerco) sale

 

Further to the announcement on 3(rd) May 2023, Johnson Matthey Plc (JM) is
pleased to announce that it has completed the sale of its Diagnostic Services
business on 29(th) September 2023 in accordance with the terms of the sale
agreement entered into between JM and Sullivan Street Partners for a
consideration of £55 million.

 

 

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and
healthier world. With over 200 years of sustained commitment to innovation and
technological breakthroughs, we improve the performance, function and safety
of our customers' products. Our science has a global impact in areas such as
low emission transport, pharmaceuticals, chemical processing and making the
most efficient use of the planet's natural resources. Today more than 15,000
Johnson Matthey professionals collaborate with our network of customers and
partners to make a real difference to the world around us. For more
information, visit www.matthey.com (http://www.matthey.com)

 

 

ENDS

 

 Enquiries:

 Investor Relations

 Martin Dunwoodie    Director of Investor Relations      020 7269 8241

 Louise Curran       Senior Investor Relations Manager   020 7269 8235

 Carla Fabiano       Senior Investor Relations Manager   020 7269 8004

 Media

 Harry Cameron       Teneo                               020 7353 4200

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774

Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCGZMGGFMKGFZM